CIK: 0001325083 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 15, 2018
Total Value ($000): $97,391 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Abeona Therapeutics Inc | 2,359,767 | $33,863 | 34.8% | $4.97 | — | COM | 00289Y107 |
| — | Corbus Pharmaceuticals HLDGS | 3,856,985 | $23,528 | 24.2% | $4.41 | — | COM | 21833P103 |
| — | Biohaven Pharmactl Hldg Co L | 749,815 | $19,315 | 19.8% | $25.00 | — | COM | G11196105 |
| — | Ampio Pharmaceuticals Inc. | 2,595,484 | $8,825 | 9.1% | $6.03 | — | COM | 03209T109 |
| KRYS | Krystal Biotech Inc | 300,000 | $3,027 | 3.1% | $10.08 | -2.2% | COM | 501147102 |
| — | Vascular Biogenics LTD | 896,771 | $2,063 | 2.1% | $4.71 | — | COM | M96883109 |
| AVXL | Anavex Life Sciences Corp | 724,205 | $1,999 | 2.1% | $3.56 | -20.7% | COM NEW | 032797300 |
| — | Soligenix Inc. | 837,800 | $1,638 | 1.7% | $2.11 | — | COM | 834223307 |
| ALDX | Aldeyra Therapeutics Inc | 124,096 | $931 | 1.0% | $10.20 | -25.6% | COM | 01438T106 |
| VNRX | Volition RX LTD | 351,538 | $844 | 0.9% | $3.75 | -22.1% | COM | 928661107 |
| — | Eiger Biopharmaceuticals Inc | 75,238 | $741 | 0.8% | $9.85 | — | COM | 28249U105 |
| — | Evoke Pharma Inc | 275,000 | $572 | 0.6% | $2.99 | — | COM | 30049G104 |
| — | Advaxis Inc. | 112,500 | $45 | 0.0% | $3.96 | — | W EXP 07/15/201 | 007624117 |